EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagrogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 mug/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP 1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity
Broglio, F., Boutignon, F., Benso, A., Gottero, C., Prodam, F., Arvat, E., et al. (2002). EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 25(8), RC26-RC28 [10.1007/BF03345096].
EP1572: A novel peptido-mimetic GH secretagogue with potent and selective GH-releasing activity in man
TORSELLO, ANTONIO BIAGIO;LOCATELLI, VITTORIO;
2002
Abstract
EP1572 (JMV1843 [Aib-DTrp-DgTrp-CHO]) is a new peptido-mimetic GH secretagrogue (GHS) showing binding potency to the GHS-receptor in animal and human tissues similar to that of ghrelin and peptidyl GHS. EP1572 induces marked GH increase after sc administration in neonatal rats. Preliminary data in 2 normal young men show that: 1) acute iv EP1572 administration (1.0 mug/kg) induces strong and selective increase of GH levels; 2) single oral EP1572 administration strongly and reproducibly increases GH levels even after a dose as low as 0.06 mg/kg. Thus, EP 1572 is a new peptido-mimetic GHS with potent and selective GH-releasing activity
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
